Article successfully added.

CyFlow™ c-Myc Biotin

CyFlow™ c-Myc Biotin
Antibody: Yes
Antigen: c-Myc
Application: Flow cytometry
Clonality: monoclonal
Clone: 9E10
Field of Interest: Epitope tags
Format/Fluorochrome: Biotin
Isotype: IgG1
Regulatory Status: RUO
Source Species: Mouse
Target Species: Fusion Proteins, Human
Product number: AJ852400

For Research Use Only

$160.00 USD*

Price excludes any applicable taxes plus shipping costs

Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 mL... more
CyFlow™ c-Myc Biotin
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenSynthetic peptide sequence (AEEQKLISEEDLL) corresponding to the C-terminal region of human c-Myc
UsageThe reagent is designed for indirect immunofluorescence analysis by Flow Cytometry. Working concentrations should be determined by the investigator.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Persson H, Hennighausen L, Taub R, DeGrado W, Leder P: Antibodies to human c‑myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science. 1984 Aug 17; 225(4663):687‑93. < PMID: 6431612 > | Evan GI, Lewis GK, Ramsay G, Bishop JM: Isolation of monoclonal antibodies specific for human c‑myc proto‑oncogene product. Mol Cell Biol. 1985 Dec; 5(12):3610‑6. < PMID: 3915782 > | Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E, Agnantis NJ: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res . 1987; 7(6):1299‑304. < PMID: 3327455 > | Siegel J, Brandner G, Hess RD: Cross‑reactivity of the monoclonal antibody 9E10 with murine c‑MYC. Int J Oncol. 1998 Dec; 13(6):1259‑62. < PMID: 9824641 > | Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K: Function of the c‑Myc oncogenic transcription factor. Exp Cell Res. 1999; 253(1):63‑77. < PMID: 10579912 > | Prendergast GC: Mechanisms of apoptosis by c‑Myc. Oncogene . 1999; 18(19):2967‑2987. < PMID: 10378693 > | Boxer LM, Dang CV: Translocations involving c‑myc and c‑myc function. Oncogene. 2001; 20(40):5595‑5610. < PMID: 11607812 > | Hilpert K, Hansen G, Wessner H, Kuttner G, Welfle K, Seifert M, Hohne W: Anti‑c‑myc antibody 9E10: epitope key positions and variability characterized using peptide spot synthesis on cellulose. Protein Eng. 2001 Oct; 14(10):803‑6. < PMID: 11739900 > | Hoffman B, Amanullah A, Shafarenko M, Liebermann DA: The proto‑oncogene c‑myc in hematopoietic development and leukemogenesis. Oncogene. 2002; 21(21):3414‑3421. < PMID: 12032779 > | Cermák L, Símová S, Pintzas A, Horejsí V, Andera L: Molecular mechanisms involved in CD43‑mediated apoptosis of TF‑1 cells: Roles of transcription Daxx expression, and adhesion molecules. J Biol Chem. 2002 Mar 8; 277(10):7955‑61. < PMID: 11773067 > | Baggio R, Burgstaller P, Hale SP, Putney AR, Lane M, Lipovsek D, Wright MC, Roberts RW, Liu R, Szostak JW, Wagner RW: Identification of epitope‑like consensus motifs using mRNA display. J Mol Recognit. 2002 May-Jun; 15(3):126‑34. < PMID: 12203838 > | Fujiwara K, Poikonen K, Aleman L, Valtavaara M, Saksela K, Mayer BJ: A single‑chain antibody/epitope system for functional analysis of protein‑protein interactions. Biochemistry. 2002 Oct 22; 41(42):12729‑38. < PMID: 12379115 > | Wang X, Campoli M, Ko E, Luo W, Ferrone S: Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti‑tag monoclonal antibodies. J Immunol Methods. 2004 Nov; 294(1‑2):23‑35. < PMID: 15604013 > | Veracini L, Simon V, Richard V, Schraven B, Horejsi V, Roche S, Benistant C: The Csk‑binding protein PAG regulates PDGF‑induced Src mitogenic signaling via GM1. J Cell Biol. 2008 Aug 11; 182(3):603‑14. < PMID: 18695048 > | Jelínková I, Šafaříková B, Blanářová OV, Skender B, Hofmanová J, Sova P, Moyer MP, Kozubík A, Kolář Z, Ehrmann J, Vaculová AH: Platinum (IV) complex LA‐12 exerts higher ability than cisplatin to enhance TRAIL‐induced cancer cell apoptosis via stimulation of mitochondrial pathway. Biochem pharmacology. 2014 Dec 1; 92(3):415‐24. < PMID: 25285768 >